HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,206,263 | +5.1% | 80,445 | -0.1% | 0.01% | 0.0% |
Q2 2023 | $6,855,728 | +15.2% | 80,523 | +11.9% | 0.01% | +16.7% |
Q1 2023 | $5,953,035 | +9.7% | 71,940 | +4.3% | 0.01% | 0.0% |
Q4 2022 | $5,424,412 | +33.2% | 68,969 | +25.4% | 0.01% | +20.0% |
Q3 2022 | $4,073,000 | +24.7% | 55,017 | +9.8% | 0.01% | +66.7% |
Q2 2022 | $3,267,000 | -0.9% | 50,128 | -3.9% | 0.00% | 0.0% |
Q1 2022 | $3,298,000 | +27.3% | 52,182 | +6.8% | 0.00% | +200.0% |
Q4 2021 | $2,591,000 | -39.2% | 48,860 | -19.1% | 0.00% | -50.0% |
Q3 2021 | $4,262,000 | -17.0% | 60,386 | -21.5% | 0.00% | -33.3% |
Q2 2021 | $5,133,000 | -22.5% | 76,938 | +29.0% | 0.00% | 0.0% |
Q1 2021 | $6,621,000 | -72.4% | 59,634 | -70.4% | 0.00% | -75.0% |
Q4 2020 | $23,957,000 | +86.3% | 201,752 | +36.9% | 0.01% | +50.0% |
Q3 2020 | $12,857,000 | +69.9% | 147,363 | +74.4% | 0.01% | +60.0% |
Q2 2020 | $7,567,000 | -76.6% | 84,514 | -73.9% | 0.01% | -82.1% |
Q1 2020 | $32,280,000 | +79.8% | 323,900 | +107.3% | 0.03% | +115.4% |
Q4 2019 | $17,956,000 | +156.1% | 156,274 | +181.2% | 0.01% | +116.7% |
Q3 2019 | $7,011,000 | -9.7% | 55,579 | -13.8% | 0.01% | -14.3% |
Q2 2019 | $7,762,000 | -8.8% | 64,504 | -33.7% | 0.01% | -12.5% |
Q1 2019 | $8,515,000 | -0.3% | 97,327 | +14.1% | 0.01% | -11.1% |
Q4 2018 | $8,537,000 | -37.6% | 85,329 | -28.5% | 0.01% | -25.0% |
Q3 2018 | $13,677,000 | +21.6% | 119,370 | -4.8% | 0.01% | +9.1% |
Q2 2018 | $11,248,000 | +56.4% | 125,426 | +27.6% | 0.01% | +57.1% |
Q1 2018 | $7,191,000 | +38.3% | 98,275 | +9.8% | 0.01% | +40.0% |
Q4 2017 | $5,198,000 | +5.6% | 89,514 | -18.4% | 0.01% | 0.0% |
Q3 2017 | $4,923,000 | +65.3% | 109,719 | +45.5% | 0.01% | +66.7% |
Q2 2017 | $2,978,000 | -1.5% | 75,411 | +1.3% | 0.00% | 0.0% |
Q1 2017 | $3,022,000 | -7.7% | 74,468 | -8.5% | 0.00% | 0.0% |
Q4 2016 | $3,273,000 | +51.9% | 81,407 | +36.9% | 0.00% | +50.0% |
Q3 2016 | $2,155,000 | +39.5% | 59,485 | +11.6% | 0.00% | 0.0% |
Q2 2016 | $1,545,000 | +27.8% | 53,324 | +54.2% | 0.00% | +100.0% |
Q1 2016 | $1,209,000 | -24.3% | 34,584 | -30.2% | 0.00% | -50.0% |
Q4 2015 | $1,597,000 | +1.9% | 49,530 | +2.1% | 0.00% | 0.0% |
Q3 2015 | $1,567,000 | -24.3% | 48,492 | -3.1% | 0.00% | 0.0% |
Q2 2015 | $2,069,000 | +25.9% | 50,056 | +36.8% | 0.00% | 0.0% |
Q1 2015 | $1,644,000 | +23.2% | 36,583 | +2.6% | 0.00% | +100.0% |
Q4 2014 | $1,334,000 | -23.7% | 35,658 | -28.8% | 0.00% | 0.0% |
Q3 2014 | $1,749,000 | +52.1% | 50,084 | +53.6% | 0.00% | 0.0% |
Q2 2014 | $1,150,000 | -77.7% | 32,610 | -79.4% | 0.00% | -80.0% |
Q1 2014 | $5,148,000 | +180.9% | 157,945 | +263.1% | 0.01% | +150.0% |
Q4 2013 | $1,833,000 | -59.8% | 43,495 | -61.9% | 0.00% | -60.0% |
Q3 2013 | $4,556,000 | +14.3% | 114,267 | +18.5% | 0.01% | +25.0% |
Q2 2013 | $3,986,000 | -0.1% | 96,414 | +0.6% | 0.00% | 0.0% |
Q1 2013 | $3,991,000 | – | 95,796 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |